Retrospective audit of continuous subcutaneous infusion of lignocaine for intractable pruritus of advance Cutaneous TCell lymphoma, 2000 to 2015

This retrospective audit examines clinical experience with subcutaneous lignocaine over a ten year period, in the management of intractable pruritus associated with mycoses fungoides/T cell lymphoma at Peter MacCallum Cancer Centre. The audit will include 19 patients treated with continuous infusions of subcutaneoous lignocaine, to assess response, side effects, effective dose and duration of response.


Peter MacCallum Cancer Centre

Principal Investigator/s

A/Prof Odette Spruyt

Palliative care consultant


A/Prof Odette Spruyt

Principal Investigator

Email: [email protected]

Publications & presentations

McDonald, JC, Alhatem, A., Buelens, O. Prince, M., Thakerar, A., Spruyt, O. First reported case series of a continuous subcutaneous infusion of lidocaine for intractable pruritus in cutaneous T-Cell Lymphoma. 2015 International MASCC/ISOO Conference, Copenhagen, Denmark,

MacDonald, J., Spruyt, O., Alhatem, A. Control of intractable pruritus in a patient with Cutaneous T- Cell Lymphoma using a Continuous Subcutaneous Infusion of Lidocaine J Pain Symptom Manage. 2015 49(4)

ANZSPM conference,2006 “Parenteral Lignocaine for itch in Mycoses Fungoides”, Newcastle, Australia